A. Bischoff

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study

Kathrin Reetz, Imis Dogan, R.-D Hilgers et al. · The Lancet Neurology · 2021 · 97 citations

Life Sciences, Neurology, Neuroscience +12

Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers.

Marija Veljača, Dubravka Pavić-Sladoljev, Boris Mildner et al. · 2002 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +13

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration

Thomas Klopstock, Aleksandar Videnović, A. Bischoff et al. · Movement Disorders · 2020 · 26 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +10

De Novo and Dominantly Inherited <scp><i>SPTAN1</i></scp> Mutations Cause Spastic Paraplegia and Cerebellar Ataxia

Liedewei Van de Vondel, Jonathan De Winter, Danique Beijer et al. · Movement Disorders · 2022 · 26 citations · Full text

Life Sciences, Genetics, Neurology +16

Functional characterization of the first missense variant in <i>CEP78</i> , a founder allele associated with cone‐rod dystrophy, hearing loss, and reduced male fertility

Giulia Ascari, Frank Peelman, Pietro Farinelli et al. · Human Mutation · 2020 · 22 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13